NCT00100672View on ClinicalTrials.gov

Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

October 31, 2009

Study Completion Date

November 30, 2010

Conditions
Neoplasms
Interventions
DRUG

LErafAON-ETU

Trial Locations (2)

85260

premiere Oncology-Arizona, Scottsdale

90404

Premiere Oncology-Santa Monica, Santa Monica

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY